# pharmacometagenomics
**Wikidata**: [Q131747006](https://www.wikidata.org/wiki/Q131747006)  
**Source**: https://4ort.xyz/entity/pharmacometagenomics

## Summary
Pharmacometagenomics is identified as a subfield of pharmacogenomics. Pharmacogenomics is the study of the role of the genome in drug response, and pharmacometagenomics is classified under that parent field.

## Key Facts
- pharmacometagenomics is classified as a subclass_of pharmacogenomics.  
- pharmacogenomics is defined as the study of the role of the genome in drug response.  
- The parent class (pharmacogenomics) has a sitelink_count of 22 in the provided metadata.  
- The topic label provided is "pharmacometagenomics."  
- Structured property available: subclass_of = pharmacogenomics.  
- No SEO data is available for pharmacometagenomics in the provided material.  
- The provided source material supplies classification-level information but does not include founding dates, creators, or versioning for pharmacometagenomics.

## FAQs
### Q: What is pharmacometagenomics?
A: Pharmacometagenomics is a subfield classified under pharmacogenomics. Pharmacogenomics is the study of the role of the genome in drug response, and pharmacometagenomics is listed as subordinate to that field.

### Q: How does pharmacometagenomics relate to pharmacogenomics?
A: Pharmacometagenomics is categorized as a subclass of pharmacogenomics, meaning it is considered part of the broader discipline that studies genomic roles in drug response.

### Q: Where can I find more metadata about pharmacometagenomics?
A: The available metadata in the provided material includes its classification (subclass_of pharmacogenomics), the parent class definition, a sitelink_count for the parent (22), and a note that no SEO data is available. No additional metadata (dates, creators, versions) is present in the source.

## Why It Matters
Pharmacometagenomics is relevant because it is formally placed within pharmacogenomics, the discipline that examines how the genome influences drug response. That classification indicates that pharmacometagenomics is part of the scientific and knowledge structure concerned with genomic contributions to pharmacological outcomes. Even when specific details about pharmacometagenomics are not present in the source material, its placement under pharmacogenomics signals that it belongs to a research and clinical context where genetic factors are investigated to understand variation in drug response. For knowledge-base organization, ontology mapping, or literature indexing, knowing that pharmacometagenomics is a subclass of pharmacogenomics is important for accurate classification, search, and linking of related resources. The current metadata highlights where additional information is missing (for example, lack of SEO data and absence of founding dates or authorship), which directs curators and researchers to seek primary sources to expand the entry.

## Notable For
- Being explicitly classified as a subclass of the field pharmacogenomics.  
- Inheriting the parent-field definition: pharmacogenomics is the study of the role of the genome in drug response.  
- Presence in the provided metadata as a discrete topic label ("pharmacometagenomics").  
- Parent-class metadata includes a sitelink_count of 22.  
- The current source-level entry lacks SEO metadata and detailed provenance (dates, creators, versions).

## Body
### Overview
- Entry label: pharmacometagenomics.
- Classified property: subclass_of pharmacogenomics.
- Parent definition supplied: "pharmacogenomics — study of the role of the genome in drug response."

### Classification details
- Taxonomic position: subordinate class within pharmacogenomics.
- Structured property explicitly recorded: subclass_of = pharmacogenomics.
- No further subclass hierarchy or sibling classes provided in the source.

### Source metadata and availability
- Parent class sitelink_count: 22 (from provided metadata).
- SEO Data Context: "No SEO data available yet" (explicit in source).
- Missing fields in source: founding dates, creators, versions, technical specifications.

### Implications for curation and research directories
- Known fact: pharmacometagenomics should be indexed under pharmacogenomics in ontologies and knowledge bases.
- Known limitation: further content development requires external sources because the provided material contains only classification-level information.

### Limitations of available information
- The provided material does not supply definitions beyond parent-field meaning.
- No empirical data, dates, people, institutions, or publications are included.
- No claims about scope, methods, or applications are supported by the source and therefore are not stated here.